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Background: Green chemistry is a rapidly developing new field that provides us with a proactive avenue for the
sustainable development of future science and technologies. Green chemistry uses highly efficient and environmentally
benign synthetic protocols to deliver lifesaving medicines, accelerating lead optimization processes in drug discovery,
with reduced unnecessary environmental impact. From this view point, it is desirable to use water instead of organic
solvents as a reaction medium, since water is safe, abundant and an environmentally benign solvent.
Results: A convenient one-pot method for the efficient synthesis of the novel Zwitterion derivatives 4a-p via a
three-component condensation reaction of barbituric acid derivatives 1a,b, dimedone 2, and various aldehydes
3 in the presence of aqueous diethylamine media is described. This new approach is environmentally benign,
with clean synthetic procedure, short reaction times and easy work-up procedure which proceeded smoothly to
provide excellent yield (88-98%). The synthesized products were characterized by elemental analysis, IR, MS, NMR and
CHN analysis. The structure of 4a was further confirmed by single crystal X-ray diffraction. The compound crystallizes in
the orthorhombic space group Pbca with α = 14.6669 (5) Å, b = 18.3084 (6) Å, c = 19.0294 (6) Å, α = 90°, β = 90°, = 90°,
V = 5109.9 (3) Å3, and Z = 8. The molecules are packed in crystal structure by weak intermolecular C–H⋅ ⋅ ⋅O hydrogen
bonding interactions.
Conclusions: An environmentally benign Aldol-Michael protocol for the synthesis of dimedone-barbituric derivatives
using aqueous diethylamine medium is achieved.
Keywords: Tandem Aldol-Michael reactions, MCRs, Barbituric acid, Aqueous media, Green chemistry, Dimedone,
ZwitterionsBackground
Recently, the development of environmentally benign
and clean synthetic procedures has become the goal of
organic synthesis. Water plays an essential role in life
processes and also as a medium for organic reactions [1,2].
The use of water as a reaction medium exhibits remarkable
benefit because of its high polarity and therefore immisci-
bility with most organic compounds. Reactions in aqueous* Correspondence: ambarakat@ksu.edu.sa
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otherwise stated.media are environmentally safe and have less carcinogenic
effects with a simple work up procedure which are
especially important in industry. Thus, there is a need
for developing multicomponent reactions (MCR’s) in
water, without the use of any harmful organic solvents.
On the other hand, due to the diverse biological proper-
ties of barbituric acid derivatives (1), there is a widespread
interest in their synthesis [3-7]. Compounds alkylated in
the fifth position have demonstrated anticancer, HIV-1
and HIV-2 protease inhibitors [8], sedative-hypnotic [9,10]
and anticonvulsant [11] properties. Many of their rep-
resentatives have clinical use as anti-inflammatory [12]
and hypnotic drugs, such as veronal, phenobarbital, sec-
onal, bucolone and sodium pentothal (Figure 1) [13-15]. Aral Ltd. This is an Open Access article distributed under the terms of the Creative
commons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
main/zero/1.0/) applies to the data made available in this article, unless
Figure 1 Bioactive compounds containing the barbituric acid framework.
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thesized with diverse pharmacological activities [16,17].
Dimedone (5,5-dimethylcyclohexane-1,3-dione) 2 belongs
to the cyclic 1,3-diketones – a very important class of or-
ganic compounds. A wide range of practical applications
of dimedone include their uses as versatile precursors for
synthesis of numerous hetero and spirocyclic compounds
[18], xanthene derivatives with their industrial [19] and
synthetic [20] applications, and also as reagent for various
analytical determinations [21].
As a part of our work on one-pot multicomponent
reactions (MCRs) for the synthesis of various heterocyclic
compounds, we report here a highly efficient procedure
for the preparation of dimedone-barbituric derivatives
based on tandem Aldol-Michael reactions using aqueous
diethylamine medium.
Results and discussion
In a typical experimental procedure, a mixture of barbituric
acid 1a,b, dimedone 2 and aromatic aldehyde 3 in water
was stirred in the presence of a stoichiometric amount of
diethylamine (1.0 equiv.) to afford the ‘Zwitterion adduct
salts’ of dimedone-barbituric acid derivative 4a in high
yields (Scheme 1).
A possible mechanism for the tandem Aldol- Michael
reaction is shown in Figure 2. In the first step of the
reaction, olefin is produced by a Aldol condensation
between aryl aldehyde 3 and 1a,b promoted by DEA.
Dimedone in the presence of DEA is then converted to its
corresponding diethylammonium dimedonate that easily
reacts with olefin to give product 4a-p [22-31].
In the absence of DEA, the reaction does not proceed
efficiently and only a poor yield of products was obtained
after 10 h. The structures of products were confirmed by
physical and spectroscopic (IR, MS, NMR) data, and by
elemental analysis. The workup procedure is very simple
and the products do not require further purification.
The X-ray zwitterion structure of 4a (Figure 3) was
obtained using X-ray structure determination from a
single crystal grown from CHCl3/Et2O as solvents. The
structure shows interesting characteristics (Table 1). Wewere unable to determine the location of the C6 and C14
hydrogens by 1HNMR analysis. This is because the
hydrogen from C6 dimedone, rather than hydrogen
from C14 of the barbituric acid moiety, is removed by the
basicity of diethylamine. This was confirmed by the X-ray
structure because one hydrogen is on the diethylamine
and the other is involved in hydrogen bonding interac-
tions between both barbituric acid and dimedone moiety.
The hydrogen-bonding interactions are listed in Table 2.
Figure 4 depicts the packing of the molecules in the crystal
structure. The crystal structure is stabilized by C–H⋅ ⋅ ⋅O
hydrogen bonds into a three-dimensional framework struc-
ture. It is noteworthy to mention that 1HNMR have also
shown a singlet signal at δ 15.28 ppm which can be
assigned to the OH group which makes a hydrogen bond.
With the optimal reaction conditions established, the
generality of the Aldol-Michael reactions was next investi-
gated by using a series of aryl aldehyde 3 (Table 3). Various
aldehydes derivatives with either electron-withdrawing or
electron-donating groups at the para-, meta-, or even ster-
ically hindered ortho-position on the aromatic ring were
tolerated and gave the corresponding condensed products
4a-p in excellent chemical yield up to 98% (Scheme 2).
Conclusions
In summary, a mild, efficient, and expeditious method has
been developed for the synthesis of zwitterion-condensed
products 4a-p via a three component; one-pot cyclocon-
densation reaction of aromatic aldehyde, barbituric acid,
and dimedone using aqueous diethylamine medium. The
main advantage of the present methodology is a simple
work-up procedure with milder reaction conditions. This
method provides excellent yields of the products with high
selectivity. Further studies on expanding the applica-
tion of this method and the biological evaluation of these
dimedone-barbituric derivatives are in progress.
Experimental section
General
All chemicals were purchased from Aldrich, Sigma-Aldrich,























































Scheme 1 Synthesis of 4a.
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on a Gallenkamp melting point apparatus in open glass
capillaries and are uncorrected. IR Spectra were measured
as KBr pellets on a Nicolet 6700 FT-IR spectrophotom-
eter. The NMR spectra were recorded on a Jeol-400
NMR spectrometer. 1H NMR (400 MHz), and 13C NMR
(100 MHz) were run in either deuterated dimethylsulphox-
ide (DMSO-d6) or deuterated chloroform (CDCl3). Chem-
ical shifts (δ) are referred in terms of ppm and J -coupling
constants are given in Hz. Mass spectra were recorded on a
Jeol of JMS-600H. Elemental analysis was carried out on an
Elmer 2400 Elemental Analyzer; CHN mode.
General procedure for aldol condensation Michael addition
for the synthesis of 4a-p (GP1)
A mixture of aldehyde 3 (1.5 mmol), dimedone 2
(1.5 mmol), barbituric acid derivatives 1a,b (1.5 mmol) and
Et2NH (1.5 mmol, 155 μL) in 1.5 mL of degassed H2O was
stirred at room temperature for 1–2 hours until TLC
showed complete disappearance of the reactants. Theproduct precipitated and the mixture was filtered and
washed with ether (3 × 20 mL). The solid was recrystal-





4a was prepared from 1,3-dimethylbarbituric acid 1a,
dimedone 2 and benzaldehyde according to the general
procedure (GP1) yielding colorless crystalline material
(671 mg, 1.47 mmol, 98%). m.p: 159°C; IR (KBr, cm–1):
3150, 2959, 1667, 1617, 1585, 1422, 1256, 1227; 1H NMR
(400 MHz, CDCl3): δ 15.28 (s, 1H, OH), 7.17-7.04 (m, 5H,
Ph), 5.85 (s, 1H, benzyl-H), 3.29 (s, 12H, 4CH3), 2.96 (q,
4H, J = 7.3 Hz, CH2CH3), 2.42 (d, 2H, J = 5.1 Hz, CH2),
2.29 (m, 2H, CH2), 1.24 (t, 6H, J = 7.3 Hz, CH2CH3), 1.14
(s, 3H, CH3), 1.05 (s, 3H, CH3);
13C NMR (100 MHz,
CDCl3): δ = 192.5, 180.8, 152.5, 142.5, 128.0, 126.7, 125.1,
116.3, 90.9, 51.4, 45.9, 42.2, 33.0, 31.5, 29.6, 28.4, 27.6, 11.4;
Figure 2 A possible mechanistic pathway.
Barakat et al. Chemistry Central Journal 2014, 8:9 Page 4 of 9
http://journal.chemistrycentral.com/content/8/1/9LC/MS (ESI): 457 [M]+; Anal. for C25H35N3O5; calcd: C,
65.62; H, 7.71; N, 9.18; Found: C, 65.61; H, 7.73; N, 9.20.
The structure of 4a was confirmed by X-ray crystal struc-
ture analysis. CCDC- 933624 contains the supplementary
crystallographic data for this compound. This data can
be obtained free of charge from the Cambridge Crystal-
lographic Data Centre via www.ccdc.cam.ac.uk/data_re-
quest/cif. A colorless crystal suitable for X-ray analysis
was obtained from recrystallization of the compound from




4b was prepared from 1,3-dimethylbarbituric acid 1a,
dimedone 2 and p-tolualdehyde according to the general
procedure (GP1) yielding an oily material (685 mg,
1.45 mmol, 97%). IR (KBr, cm–1): 3150, 2954, 2867, 1675,
1580, 1508, 1447, 1380, 1256, 1145; 1H NMR (400 MHz,
CDCl3): δ 15.25 (s, 1H, OH), 7.00-6.93 (m, 4H, Ph), 5.84
(s, 1H, benzyl-H), 3.28 (s, 12H, 4CH3), 2.90 (q, 4H, J = 7.3
Hz, CH2CH3), 2.30 (d, 4H, J = 5.1 Hz, CH2), 2.22 (s, 3H,
CH3), 1.20 (t, 6H, J = 7.3 Hz, CH2CH3), 1.16 (s, 3H, CH3),
1.04 (s, 3H, CH3);
13C NMR (100 MHz, CDCl3): δ = 196.5,
180.1, 152.8, 140.5, 134.2, 129.8, 128.7, 126.8, 126.7, 115.6,
91.0, 51.4, 45.9, 42.5, 32.6, 31.5, 29.6, 28.4, 27.6, 20.9,





4c was prepared from 1,3-dimethylbarbituric acid 1a,
dimedone 2 and p-chlorobenzaldehyde 3 according to
the general procedure (GP1) yielding an oily material
(715 mg, 1.45 mmol, 97%). IR (KBr, cm–1): 3151, 2955,
2868, 2497, 1675, 1580, 1481, 1444, 1379, 1258, 1206; 1H
NMR (400 MHz, CDCl3): δ 15.02 (s, 1H, OH), 7.12-6.95
(m, 4H, Ph), 5.87 (s, 1H, benzyl-H), 3.30 (s, 12H, 4CH3),
2.90 (q, 4H, J = 7.3 Hz, CH2CH3), 2.38 (s, 4H, CH2),
1.20 (t, 6H, J = 7.3 Hz, CH2CH3), 1.16 (s, 3H, CH3), 1.04
(s, 3H, CH3);
13C NMR (100 MHz, CDCl3): δ = 198.1,
181.0, 152.5, 141.5, 130.6, 128.3, 128.2, 128.0, 127.9, 115.2,
90.7, 65.9, 49.8, 42.3, 32.4, 31.5, 31.2, 29.6, 28.4, 27.6, 15.3,
11.4; LC/MS (ESI): 492 [M]+; Anal. for C25H34ClN3O5;
calcd: C, 61.03; H, 6.97; Cl, 7.21; N, 8.54; Found: C, 61.06;




4d was prepared from 1,3-dimethylbarbituric acid 1a,
dimedone 2 and p-bromobenzaldehyde 3 according to the
Figure 3 ORTEP representation of the structure of 4a.
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1.42 mmol, 95%). IR (KBr, cm–1): 3155, 2955, 2867, 2500,
1674, 1579, 1430, 1376, 1204;1H NMR (400 MHz,
CDCl3): δ 15.20 (s, 1H, OH), 7.34 (d, 2H, J = 8.0 Hz,
Ph), 6.98 (d, 2H, J = 8.0 Hz, Ph), 5.79 (s, 1H, benzyl-H),
3.27 (s, 12H, 4CH3), 2.99 (q, 4H, J = 7.3 Hz, CH2CH3), 2.40
(d, 2H, J = 5.1 Hz, CH2), 2.28 (m, 2H, CH2), 1.29 (t, 6H, J =
7.3 Hz, CH2CH3), 1.18 (s, 3H, CH3), 1.04 (s, 3H, CH3);
13C NMR (100 MHz, CDCl3): δ = 199.1, 191.2, 164.8,
152.4, 142.8, 132.5, 131.0, 129.9, 128.7, 128.6, 118.9,
115.9, 90.6, 51.2, 45.8, 42.3, 32.7, 31.5, 29.5, 28.5,
28.3, 27.6, 11.4; LC/MS (ESI): 536 [M]+; Anal. for
C25H34BrN3O5; calcd: C, 55.97; H, 6.39; Br, 14.89; N,




4e was prepared from 1,3-dimethylbarbituric acid 1a,
dimedone 2 and m-bromobenzaldehyde 3 according to
the general procedure (GP1) yielding an oily material
(745 mg, 1.39 mmol, 93%). IR (KBr, cm–1): 3050, 2955,
2868, 2500, 1675, 1581, 1444, 1378, 1255, 1205; 1H
NMR (400 MHz, CDCl3): δ 15.63 (s, 1H, OH), 7.22 (d,
1H, J = 7.3 Hz, Ph), 7.19 (s, 1H, Ph), 7.07 (d, 1H, J = 7.3 Hz,Ph), 7.05 (d, 1H, J = 7.3 Hz, Ph), 5.84 (s, 1H, benzyl-H),
3.34 (s, 6H, 2CH3), 3.32 (s, 6H, 2CH3), 2.98 (q, 4H, J =
7.3Hz, CH2CH3), 2.31 (d, 4H, J = 5.1 Hz, CH2), 1.24 (t, 6H,
J = 7.3 Hz, CH2CH3), 1.12 (s, 3H, CH3), 1.03 (s, 3H,
CH3);
13C NMR (100 MHz, CDCl3): δ = 190.8, 186.4,
165.2, 164.4, 151.7, 144.7, 129.7,129.6, 128.7, 125.3, 91.5,
42.1, 34.4, 28.9, 28.7, 11.5; LC/MS (ESI): 536 [M]+; Anal.
for C25H34BrN3O5; calcd: C, 55.97; H, 6.39; Br, 14.89; N,




4f was prepared from 1,3-dimethylbarbituric acid 1a,
dimedone 2 and anisaldehyde 3 according to the general
procedure (GP1) yielding an oily material (672 mg,
1.38 mmol, 92%). IR (KBr, cm–1): 3047, 2953, 2866,
2499, 1679, 1577, 1510, 1427, 1373, 1255, 1214;1H NMR
(400 MHz, CDCl3): δ 15.26 (s, 1H, OH), 6.98 (d, 2H, J =
8.0 Hz, Ph), 6.72 (d, 2H, J = 8.0 Hz, Ph), 5.69 (s, 1H,
benzyl-H), 3.71 (s, 3H, CH3), 3.29 (s, 12H, 4CH3), 2.87
(q, 4H, J = 7.3 Hz, CH2CH3), 2.31 (d, 4H, J = 5.1 Hz, CH2),
1.19 (t, 6H, J = 7.3 Hz, CH2CH3), 1.12 (s, 3H, CH3), 1.03
(s, 3H, CH3);
13C NMR (100 MHz, CDCl3): δ = 195.1,
187.2, 157.1, 134.5, 133.9, 127.8, 127.6, 115.6, 113.4,







Cu Kα radiation, λ 1.54178 Å
a = 14.6669 (5) Å
b = 18.3084 (6) Å




V = 5109.9 (3) Å3
Z = 8
Theta range for data collection 3.0–69.2°
μ = 0.70 mm−1
Density clac. (g/cm3) 1.187
Crystal shape and colour Plate, colourless
Crystal size 0.89 × 0.78 × 0.22 mm
h/k/l −17,17/-22,22/-22,23
Measured reflections 32924
Independent reflections 4796 (Rint = 0.088)
Reflections with I > 2σ(I) 3997
Goodness-of-fit on F2 1.04
R[F2 > 2σ(F2)] = 0.067
wR(F2) = 0.195
Δρmax = 0.47 e Å−3
Δρmin = −0.40 e Å−3
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Anal. for C26H37N3O6; calcd: C, 64.05; H, 7.65; N, 8.62;




4b was prepared from 1,3-dimethylbarbituric acid 1a,
dimedone 2 and p-nitrobenzaldehyde 3 according to theTable 2 Hydrogen-bond geometry (Å, °)
D—H · · · A D—H H · · · A D · · · A D—H · · · A
C2—H2B · · · O1 0.9600 2.2600 2.655(3) 104.00
C4—H4B · · · O3 0.9600 2.2300 2.682(3) 108.00
C7—H7A · · · O1 0.9800 2.3700 2.894(2) 113.00
C7—H7A · · · O5 0.9800 2.2800 2.821(2) 114.00
C22—H22A · · · O3i 0.9600 2.5400 3.376(3) 146.00
Symmetry code: (i) x, −y + 3/2, z + 1/2.general procedure (GP1) yielding a beige material (700 mg,
1.39 mmol, 93%). m.p: 148°C; IR (KBr, cm–1): 3050, 2950,
2865, 2500, 1669, 1580, 1510, 1427, 1373, 1255, 1214;1H
NMR (400 MHz, CDCl3): δ 15.26 (s, 1H, OH), 6.99
(d, 2H, J = 8.0 Hz, Ph), 6.72 (d, 2H, J = 8.8 Hz, Ph), 5.69 (s,
1H, benzyl-H), 3.71 (s, 12H, 4CH3), 2.85 (q, 4H, J= 7.3Hz,
CH2CH3), 2.31 (d,4H, J= 14.7Hz, CH2), 1.19 (t, 6H, J= 7.3
Hz, CH2CH3), 1.12 (s, 3H, CH3), 1.03 (s, 3H, CH3);
13C
NMR (100 MHz, CDCl3): δ= 161.6, 153.2, 145.5, 141.6,
129.1, 128.2, 127.8, 125.8, 88.5, 49.1, 41.9, 27.5, 11.5; LC/MS
(ESI): 502 [M]+; Anal. for C25H34N4O7; calcd: C, 59.75; H,
6.82; N, 11.15; Found: C, 59.73; H, 6.81; N, 11.17.5-((2,4-Dichlorophenyl)(2-hydroxy-4,4-dimethyl-6-oxocyclohex-
1-en-1-yl)methyl)-1,3-dimethyl-2,6-dioxo-1,2,3,
6-tetrahydropyrimidin-4-olate (4 h)
4 h was prepared from 1,3-dimethylbarbituric acid 1a,
dimedone 2 and 2,4-dichlorobenzaldehyde 3 according to
the general procedure (GP1) yielding a beige solid mater-
ial (710 mg, 1.35 mmol, 90%). m.p: 164°C; IR (KBr, cm–1):
3059, 2995, 2867, 2114, 1741, 1658, 1591, 1463, 1429, 1370,
1341, 1256, 12011H-NMR (400 MHz, CDCl3): δ 14.80
(s, 1H, OH), 7.29 (d, 1H, J = 8.0 Hz, Ph), 7.19 (s, 1H, Ph),
7.12 (d, 2H, J = 8.0 Hz, Ph), 5.76 (s, 1H, benzyl-H), 3.28
(s, 12H, 4CH3), 3.07 (q, 4H, J = 7.3 Hz, CH2CH3), 2.37
(s, 2H, CH2), 2.27 (d, 2H, J = 5.1 Hz, CH2), 1.34 (t, 6H, J =
7.3 Hz, CH2CH3), 1.04 (s, 3H, CH3), 1.01 (s, 3H, CH3);
13C
NMR (100 MHz, CDCl3): δ = 199.1, 165.4, 164.4, 152.5,
139.8, 133.6, 131.7, 131.2, 129.3, 126.4, 115.7, 89.8, 51.2,
45.7, 41.9, 32.4, 31.2, 28.3, 28.2, 11.3; LC/MS (ESI): 526
[M]+; Anal. for C25H33Cl2N3O5; calcd: C, 57.04; H, 6.32;




4i was prepared from 1,3-dimethylbarbituric acid 1a,
dimedone 2 and 2,6-dichlorobenzaldehyde 3 according
to the general procedure (GP1) yielding an oily material
(702 mg, 1.33 mmol, 89%). IR (KBr, cm–1): 3048, 2955,
2869, 2728, 2494, 1676, 1575, 1428, 1372, 1238, 1196;1H
NMR (400 MHz, CDCl3): δ 14.80 (s, 1H, OH), 7.36 (d, 2H,
J = 8.0Hz, Ph), 7.29 (t, 1H, J = 8.0 Hz, Ph), 7.12 (d, 2H, J =
8.0Hz, Ph), 5.98 (s, 1H, benzyl-H), 3.26 (s, 12H, 4CH3), 2.92
(q, 4H, J = 7.3Hz, CH2CH3), 2.37 (s, 2H, CH2), 2.27 (d, 2H,
J = 5.1 Hz, CH2), 1.24(t, 6H, J = 7.3 Hz, CH2CH3), 1.094
(s, 3H, CH3), 1.04 (s, 3H, CH3);
13C NMR (100 MHz,
CDCl3): δ = 192.8, 188.9, 165.3, 164.3, 152.5, 149.7, 137.4,
131.5, 129.8, 126.5, 124.2, 115.5, 114.7, 89.9, 53.5, 41.4,
31.9, 28.7, 28.2, 11.4 ; LC/MS (ESI): 526 [M]+; Anal. for
C25H33Cl2N3O5; calcd: C, 57.04; H, 6.32; Cl, 13.47; N,
7.98; Found: C, 57.08; H, 6.30; Cl, 13.45; N, 8.00.
Figure 4 Crystal packing showing intermolecular C–H⋅O hydrogen bonds as dashed lines. 4a.




4j was prepared from 1,3-dimethylbarbituric acid 1a, dime-
done 2 and 2-naphthaldehyde 3 according to the general
procedure (GP1) yielding a white solid material (715 mg,
1.41 mmol, 94%). m.p: 170 °C; IR (KBr, cm–1): 2994, 2948,Table 3 Tandem Aldol-Michael reactions of barbituric acid
1a,b and dimedone 2 with aldehydes 3 in aqueous
diethylamine mediuma
# 3 R1 R2 yield (%)
b
1 4a CH3 Ph 98
2 4b CH3 p-CH3Ph 97
3 4c CH3 p-ClPh 97
4 4d CH3 p-BrPh 95
5 4e CH3 m-BrPh 93
6 4f CH3 p-CH3OPh 92
7 4 g CH3 o-NO2Ph 93
8 4 h CH3 2,4-Cl2Ph 90
9 4i CH3 2,6-Cl2Ph 89
10 4j CH3 2-Naphthaldehyde 94
11 4 k CH3 p-HO-Ph 91
12 4 l H Ph 93
13 4 m H p-CH3Ph 91
14 4n H p-ClPh 90
15 4o H p-BrPh 89
16 4p H 2-Naphthaldehyde 90
aAll reactions were carried out with barbituric acid derivatives 1a,b (1.5 mmol),
dimedone 2 (1.5 mmol) aldehydes 3 (1.5 mmol) and diethylamine (1.5 mmol)
in water (1.5 mL) for the specified time. bYield of isolated product 4a-p.2866, 2506, 1742, 1651, 1603, 1570, 1526, 1473, 1431,
1362, 1245;1H NMR (400 MHz, CDCl3): δ 14.26 (s, 1H,
OH), 7.46-7.22 (m, 7H, naphthyl), 6.20 (s, 1H, benzyl-H),
3.26 (s, 6H, 2CH3), 3.23 (s, 6H, 2CH3), 3.14 (q, 4H, J = 7.3
Hz, CH2CH3), 2.41 (q, 4H, J = 5.1Hz, CH2), 2.23 (s, 2H,
CH2), 1.37 (t, 6H, J = 7.3Hz, CH2CH3), 1.07 (s, 3H, CH3),
1.01 (s, 3H, CH3);
13C NMR (100 MHz, CDCl3): δ = 199.0,
180.5, 165.3, 164.3, 152.5, 149.7, 136.8, 131.5, 129.9, 126.5,
124.2, 115.5, 114.7, 89.9, 50.9, 45.5, 41.7, 31.3, 30.7, 28.2,
11.1; LC/MS (ESI): 507 [M]+; Anal. for C29H37N3O5; calcd:




4 k was prepared from 1,3-dimethylbarbituric acid 1a, dime-
done 2 and p-hydroxybenzaldehyde 3 according to the
general procedure (GP1) yielding a white solid material
(645 mg, 1.36 mmol, 91%). m.p: 162°C; IR (KBr, cm–1):
23097, 2939, 2884, 2828, 2498, 1747, 1574, 1530, 1506,
1466, 1384, 1241;1H NMR (400 MHz, DMSO-d6): δ 14.52
(s, 1H, OH), 8.50 (brs, 1H, OH), 6.76 (d, 2H, J = 8.0Hz, Ph),
6.50 (d, 2H, J= 8.0Hz, Ph), 6.04 (s, 1H, benzyl-H), 3.07 (s,
12H, 2CH3), 3.14 (q, 4H, J=7.3Hz, CH2CH3), 2.92 (q, 4H, J=
13.9Hz, CH2), 206 (s, 4H, CH2), 1.12 (t, 6H, J=7.3Hz, CH2CH3),
0.98 (s, 3H, CH3);
13C NMR (100 MHz, DMSO-d6): δ=198.0,
188.5, 154.1, 136.6, 128.3, 115.3, 114.3, 90.1, 50.9, 45.5, 42.1, 31.6,
30.7, 29.7, 11.7; LC/MS (ESI): 473 [M]+; Anal. for C25H35N3O6;
calcd: C, 63.41; H, 7.45; N, 8.87; Found: C, 63.40; H, 7.43; N, 8.85.
5-((2-Hydroxy-4,4-dimethyl-6-oxocyclohex-1-en-1-yl)(phenyl)
methyl)-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-olate (4 l)
4 m was prepared from barbituric acid 1b, dimedone 2


























Scheme 2 Synthesis of 4a-p.
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93%). m.p: 215°C; IR (KBr, cm–1): 3027, 2948, 2867, 2156,
1683, 1593, 1451, 1374, 1291, 1257, 11411H-NMR
(400 MHz, CDCl3): δ 12.26 (s, 1H, OH), 9.31 (brs, 2H,
NH), 7.12 (m, 5H, Ph), 5.52 (s, 1H, benzyl-H), 2.99 (q, 4H,
J = 7.3 Hz, CH2CH3), 2.45 (d, 4H, J = 5.1 Hz, CH2), 1.24
(t, 6H, J = 7.3 Hz, CH2CH3), 1.09 (s, 3H, CH3), 1.03 (s, 3H,
CH3);
13C NMR (100 MHz, CDCl3): δ = 198.5, 180.8,
152.5, 142.5, 128.0, 126.7, 125.1, 116.3, 90.9, 51.4, 45.9,
42.2, 33.0, 28.4, 27.6, 11.3; LC/MS (ESI): 429 [M]+; Anal.
for C23H31N3O5; calcd: C, 64.32; H, 7.27; N, 9.78; Found:
C, 64.29; H, 7.29; N, 9.80.
5-((2-Hydroxy-4,4-dimethyl-6-oxocyclohex-1-en-1-yl)(p-tolyl)
methyl)-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-olate (4 m)
4n was prepared from barbituric acid 1a, dimedone 2 and
tolualdehyde 3 according to the general procedure (GP1)
yielding a white solid material (604 mg, 1.36 mmol, 91%).
m.p: 213°C; IR (KBr, cm–1): 3150, 2955, 2867, 1690, 1592,
1508, 1375, 1256, 1232, 1167; 1H NMR (400 MHz, CDCl3):
δ 13.31 (s, 1H, OH), 8.83 (brs, 2H, NH), 7.27 (d, 2H, J =
8.0Hz, Ph), 7.00 (d, 2H, J = 8.0Hz, Ph), 5.88 (s, 1H, benzyl-
H), 2.83 (q, 4H, J = 7.3Hz, CH2CH3), 2.31 (d, 4H, J = 5.1 Hz,
CH2), 2.23 (s, 3H, CH3), 1.19 (t, 6H, J = 7.3Hz, CH2CH3),
1.04 (s, 3H, CH3), 1.02 (s, 3H, CH3);
13C NMR (100 MHz,
CDCl3): δ = 196.5, 180.1, 152.8, 140.5, 131.4, 130.7, 128.7,
128.6, 118.5, 115.6, 91.0, 50.9, 42.8, 31.6, 31.5, 29.2, 28.3,
27.8, 20.9, 11.3; LC/MS (ESI): 443 [M]+; Anal. for
C24H33N3O5; calcd: C, 64.99; H, 7.50; N, 9.47; Found: C,




4o was prepared from barbituric acid 1a, dimedone 2 and
p-chlorobenzaldehyde 3 according to the general procedure
(GP1) yielding an oily product (625 mg, 1.35 mmol, 90%).
IR (KBr, cm–1): 3049, 2954, 2865, 2499, 1738, 1699, 1590,
1483, 1375, 1292, 1258, 1225, 1205; 1H NMR (400 MHz,CDCl3 δ 13.32 (s, 1H, OH), 8.83 (brs, 2H, NH), 7.27 (d, 2H,
J = 8.0 Hz, Ph), 7.00 (d, 2H, J = 8.0 Hz, Ph), 5.89 (s, 1H,
benzyl-H), 2.88 (q, 4H, J = 7.3 Hz, CH2CH3), 2.31 (d, 4H,
J = 5.1 Hz, CH2), 1.19 (t, 6H, J = 7.3 Hz, CH2CH3), 1.09
(s, 3H, CH3), 1.03 (s, 3H, CH3);
13C NMR (100 MHz,
CDCl3): δ = 190.9, 141.0, 134.8, 131.0, 129.5, 128.3, 115.3,
91.1, 47.1, 42.7, 31.6, 31.5, 29.1, 28.2, 27.8, 11.3; LC/MS
(ESI): 463 [M]+; Anal. for C23H30ClN3O5; calcd: C, 59.54;





4n was prepared from barbituric acid 1a, dimedone 2 and
p-bromobenzaldehyde 3 according to the general procedure
(GP1) yielding a white solid material (678 mg, 1.33 mmol,
89%). m.p: 208°C; IR (KBr, cm–1): 3093, 2939, 2885, 2829,
2551, 1746, 1686, 1576, 1506, 1466, 1416, 1268, 1241; 1H
NMR (400 MHz, CDCl3): δ 13.31 (s, 1H, OH), 8.67 (brs,
2H, NH), 7.05 (m, 4H, Ph), 5.79 (s, 1H, benzyl-H), 2.79
(q, 4H, J = 7.3 Hz, CH2CH3), 2.35 (d, 4H, J = 5.1 Hz, CH2),
1.21(t, 6H, J = 7.3 Hz, CH2CH3), 1.11 (s, 3H, CH3), 1.03
(s, 3H, CH3);
13C NMR (100 MHz, CDCl3): δ = 198.5,
180.1, 152.8, 140.5, 131.4, 130.7, 128.7, 128.6, 118.5, 115.6,
91.0, 50.9, 42.8, 31.6, 31.5, 29.2, 28.3, 27.8, 11.3; LC/MS
(ESI): 508 [M]+; Anal. for C23H30BrN3O5; calcd: C, 54.34;





4q was prepared from barbituric acid 1a, dimedone 2 and
2-naphthaldehyde 3 according to the general procedure
(GP1) yielding an oily product (646 mg, 1.35 mmol, 90%).
IR (KBr, cm–1): 3049, 2948, 2863, 2725, 1685, 1594, 1508,
1371, 1252, 1216; 1H NMR (400 MHz, CDCl3): δ 14.25
(s, 1H, OH), 7.46-7.22 (m, 7H, naphthyl), 6.21 (s, 1H,
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http://journal.chemistrycentral.com/content/8/1/9benzyl-H), 3.27 (s, 6H, 2CH3), 3.25 (s, 6H, 2CH3), 3.14
(q, 4H, J = 7.3 Hz, CH2CH3), 2.41 (q, 4H, J = 5.1 Hz, CH2),
2.23 (s, 2H, CH2), 1.37 (t, 6H, J = 7.3 Hz, CH2CH3), 1.07
(s, 3H, CH3), 1.01 (s, 3H, CH3);
13C NMR (100 MHz,
CDCl3): δ = 199.1, 180.5, 165.5, 164.2, 152.5, 149.7, 136.8,
131.5, 129.9, 126.5, 124.2, 115.5, 114.7, 89.9, 50.9, 45.5,
41.7, 31.3, 30.7, 28.2, 11.3; LC/MS (ESI): 479 [M]+; Anal.
for C27H33N3O5; calcd: C, 67.62; H, 6.94; N, 8.76; Found:
C, 67.65; H, 6.96; N, 8.80.
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